Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Dec;14(12):2290-6.
doi: 10.1007/s00330-004-2369-2. Epub 2004 Jun 30.

Low contrast dose voiding urosonography in children with phase inversion imaging

Affiliations

Low contrast dose voiding urosonography in children with phase inversion imaging

Andrea Kopitzko et al. Eur Radiol. 2004 Dec.

Abstract

Voiding urosonography (VUS) using a microbubble contrast agent has been introduced as an alternative technique in the diagnosis of vesicoureteral reflux (VUR). This study was undertaken to assess if phase inversion ultrasound (PIUS), a recent microbubble specific imaging technique, has advantages over fundamental in VUS and if it allows a reduction of contrast agent dose. Forty-three children with suspected VUR (aged 3 days-12 years, average of 3.9 years) with 92 kidney-ureter units (KUU) were included. Everyone obtained a baseline US scan that was followed by VUS using Levovist as the contrast agent. Constant switching between fundamental and PIUS performed the enhanced part for comparison. Every child underwent VCUG immediately afterwards. Contrast enhancement was stronger and longer lasting on PIUS than on fundamental US in all 43 cases. Reflux was detected in a total of 21 KUU, out of 92 KUU (23%). PIUS revealed VUR in 18; fundamental in 14 KUU and VCUG depicted 16 cases of reflux (p> or =0.29). The mean volume of Levovist dose administered to the bladder was 7.4+/-3.4% of the bladder volume. VUS using PI mode provided considerably stronger and longer enhancement and slightly improved the detection of VUR. It allowed a reduction of contrast dose and cost by approximately 35% over current dose recommendations for fundamental US.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Radiology. 1997 Dec;205(3):821-2 - PubMed
    1. Eur Radiol. 2003 Jan;13(1):213-8 - PubMed
    1. Br J Urol. 1976 Dec;48(6):431-5 - PubMed
    1. Urol Clin North Am. 1995 Feb;22(1):139-50 - PubMed
    1. Radiology. 1999 Jan;210(1):201-7 - PubMed

LinkOut - more resources